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Article
Efficient design of cluster
randomized and multicentre
trials with unknown intraclass
correlation
Gerard JP van Breukelen and Math JJM Candel
Abstract
For cluster randomized and multicentre trials evaluating the effect of a treatment on persons nested within
clusters, equations have been published to compute the optimal sample sizes at the cluster and person level
as a function of sampling costs and intraclass correlation (ICC). Here, optimal means maximum power and
precision for a given sampling budget, or minimum sampling costs for a given power and precision. However,
the ICC is usually unknown, and the optimal sample sizes depend strongly on this ICC. To overcome this local
optimality problem, this study presents Maximin designs (MMDs) based on relative efficiency (RE) and
efficiency. These designs perform well over a range of possible ICC values either in terms of RE
compared with the locally optimal designs, or in terms of minimum efficiency (maximum variance) of the
treatment effect estimator. The use of MMDs is illustrated using information from many cluster randomized
trials in primary care. It is concluded that MMDs and the optimal design for an ICC halfway its assumed range
are efficient for a range of ICC values and recommendable for practical use. This requires that trial reports
mention the study cost per cluster and person.
Keywords
Cluster randomized trials, cost effectiveness, efficiency, intraclass correlation, Maximin design, multicentre
trials, optimal design, power, sample size
1 Introduction
To evaluate the effect of a treatment on persons nested within clusters, for instance patients in general
practices or pupils in schools, one can randomly assign treatments to individuals within clusters
(multicentre trial) or to entire clusters (cluster randomized trial). Cluster randomized trials are
performed when randomization of individuals is logistically impossible or may lead to serious
treatment contamination. Examples are the evaluation of a smoking prevention program for
school children where the program consists of lessons in the classroom1 and patient-centred care of
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newly diagnosed diabetes in general practices.2 Data analysis has to take the nesting of persons within
clusters into account, since ignoring this leads to underestimation of the standard error of the
treatment effect estimate, and thus to a too large type I error risk and a too narrow confidence
interval. The best method is mixed regression, also known as multilevel analysis, but an unpaired
t-test on cluster means can be acceptable. The latter is even equivalent to mixed regression if the
number of persons sampled is the same for each cluster, the outcome is quantitative and there are no
covariates.3
Multicentre trials differ from cluster randomized trials in that individuals are randomized within
each centre, which is more efficient but not always possible and more prone to treatment
contamination. Again, the nesting has to be taken into account, either by mixed regression or by a
paired t-test of treated versus control with centre as unit of analysis, assuming centre is considered a
random effect. The alternative of centre as fixed effect is sometimes a better choice, depending on
various considerations including the number of centres in the study,4 but will not be covered in this
article.
The planning of both types of trials involves several design choices, including the sample size per
level, that is, the number of clusters and the number of persons per cluster. This article is about sample
size planning in cluster randomized and multicentre trials. The optimal sample size, henceforth called
the optimal design, can be defined in either of two ways, depending on the preconditions. If the total
budget for sampling and measuring clusters and persons is fixed, then the optimal design is that
which maximizes the precision of the treatment effect estimate and the power of its significance
test. If the required power for testing and precision for estimation of the treatment effect are fixed,
then the optimal design is that which minimizes the total costs for sampling and measuring clusters
and persons. Optimal trial design is of importance from the viewpoint of cost effectiveness, a criterion
by which not only medical treatments, but also scientific studies can be evaluated. After all, improving
cost effectiveness of trials allows more trials to be run with the same budget. Formulae for computing
the optimal design under either of both preconditions, power or budget, are available,5–11 but
make two restrictive assumptions: (1) the number of persons sampled is the same for each cluster
and (2) the intraclass correlation (ICC) is known, where ICC is the proportion of outcome variance
that is between clusters rather than within clusters.
These assumptions are not very plausible, as acknowledged in a recent paper on statistical
issues in trial design.12 Although equal cluster sizes are optimal,13,14 they are rarely feasible.
Variation of the actual size of general practices or schools, but also non-response and dropout of
persons, lead to unequal cluster sizes in the study and thereby to a loss of power. Likewise, the ICC is
unknown before data analysis, although systematic reviews suggest that it rarely exceeds 0.10.2,12,15–17
This is a problem since the optimal design depends on the unknown ICC value. In optimal design
literature, this is known as the local optimality problem.18,19 The problem of cluster size variation was
addressed by several authors who proposed a sample size correction based on the coefficient of
variation (CV) of cluster sizes.14,15,20–26 This article addresses the problem of an unknown ICC, by
derivingMaximin designs (MMDs) which are either highly efficient compared with the locally optimal
designs (LODs) for a range of ICC values (maximin relative efficiency), or highly efficient in the worst
case scenario of a high ICC (maximin efficiency). MMD has been applied to longitudinal studies27,28
and functional magnetic resonance imaging,29 among others, but not yet to cluster randomized and
multicentre trials. The outline of this article is as follows. Section 2 summarizes the design and ICC
values from a large number of cluster randomized trials in primary care, showing the wide variation in
cluster size and ICC as motivation for this study. Section 3 presents the mixed effects model and
current sample size formulae for cluster randomized trials with a quantitative outcome, showing how
the optimal design depends on the ICC and is thus locally optimal only. Section 4 shows how anMMD
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overcomes this dependence, and Section 5 compares the efficiency of MMDs with some simple
alternatives. Sections 6 and 7 show how the theory also applies to multicentre trials with treatment
by centre interaction and to binary outcomes. Section 8 compares the actual designs of Section 2 with
LODs and MMDs. The final section summarizes the main results and points out some limitations
addressed in ongoing work.
2 Designs and ICCs in published cluster randomized trials
A systematic review by Adams et al.16 provides information on the sample sizes and ICCs in 19 cluster
randomized trials and 12 other nested designs in primary care in the UK published between 2000 and
2002. Summaries of 152 trials worldwide and published between 1997 and 2000 are given by Eldridge
et al.17 Additional data were obtained from six trials in five papers focussing on ICC values from
specific trials which were not covered by the two reviews.30–34 Table 1 summarizes the sample sizes and
ICCs found in both reviews,16,17 showing a large variation between trials in sample sizes and ICCs.
The mean cluster size varied from 2 to 151 or from 9 to 82. The ICC ranged from 0 to 0.10 or from 0 to
0.21. The data from six further trials gave similar results and are not further discussed here. We now
turn to optimal and robust sample sizes as a function of the ICC and sampling costs, coming back to
Table 1 in Section 8.
3 Cluster randomized trials: model and optimal sample size
Suppose that a new treatment is evaluated by samplingK clusters (general practices, schools, etc.) of n
persons (patients, pupils), followed by randomized treatment assignment to clusters. Let the
effectiveness of the treatment be expressed as the mean difference between treated and control on a
quantitative outcome Y. The model for data analysis is then:
Yij ¼ 0 þ 1Xj þ u0j þ eij ð1Þ
where Yij is the outcome for person i in cluster j, and Xj the treatment assigned to cluster j and will be
coded 1 for treated and 0 for control clusters. Finally, u0j is a random cluster effect and eij a residual
error reflecting person and measurement error effects. These two random effects are assumed to be
independently and normally distributed with variances 20 and 
2
e . The outcomesYij andYi0j of any two










where the denominator is the total outcome variance within each treatment condition.








where n and K are the number of persons per cluster and the number of clusters so that nK is the total
sample size,  the ICC defined in (2), and  2Y the total outcome variance. The factor n 1ð Þþ 1½  in (3)
is known as the design effect. If  ¼ 0, the design effect is 1 and Var ̂1
 
for cluster randomization is
equal to Var ̂1
 
for individual randomization.
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To find the optimal design a cost function must be defined. Assume that inclusion of a cluster into
the study costs c currency units (e.g. Euros, GBP or USD), and that inclusion of a person (subject)
within an already included cluster costs s units, with c> s usually. The total budget B needed for
including K clusters of n persons each, excluding all study costs that do not depend on the sample size
at either level, then is:
B ¼ cKþ snK ¼ K cþ snð Þ ð4Þ
where the factor (c + sn) is the total sampling cost per cluster of size n. Finding the optimal design
means finding the K and n which minimize Var ̂1
 
in (3) given the constraint in (4). It has been
















This shows that as the ICC  increases (so that  decreases), the number of clustersKmust increase,
while the number of persons per cluster n must decrease.
Table 1. Summary of sample sizes and ICCs found in systematic reviews of cluster randomized trials in primary care in
the UK between 1997 and 2002 (IQR ¼ interquartile range).














90 percentile ¼ 0.046
95 percentile ¼ 0.075











90 percentile ¼ 0.046
95 percentile ¼ 0.099
Eldridge et al.17b 71 for sample sizes,







Notes: aThe review covered 31 studies with a nested design, of which 19 were cluster randomized, 3 were multicentre, and 9 were
surveys. ICCs based on Table 1 in Adams et al.16 and taking per study the median ICC in case of multiple outcomes.16
bSample size information was available from 71 of 152 trials, ICC information from 13 trials, first ICC quartile reported to be0.02, here
truncated to 0.
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Inserting (5) in (3) gives the variance of the treatment effect estimator for the optimal design, which




¼ g ð Þ 
42Y
B









Figure 1 shows how this minimal Var ̂1
 
depends on the ICC and the cluster size n, and implicitly on
the number of clusters K due to the constraint in (4). Hence, the power and precision for treatment
effect evaluation increase with budget B for sampling, and decrease with sampling costs c and s, in a
way which depends on the ICC. More specifically, g ð Þ runs from s if  ¼ 0 to c if  ¼ 1, with a
maximum g ð Þ ¼ cþ s, attained if  ¼ ccþs.
There are some limitations to the application of (5). Apart from the fact that the ICC is unknown,
which is addressed in the next section, a problem is that there are often boundaries on K or n. For
example, in a trial on general practice care, only 20 practices may be within reachable distance and
willing to participate. Likewise, in a smoking prevention program for school children which is
delivered in the class room, whole classes will be included and so the number of included pupils per
school may be a multiple of class size. One can then choose from all feasible designs the one which is
closest to the optimal design in terms ofK and n and adapt eitherK or n (whichever can be adapted) to
approximate the power or the budget for the optimal design.
4 Unknown intraclass correlation: MMD
Computing the optimal design with (5) requires knowledge or a guess of the ICC, and
misspecification may lead to an inefficient design with too many or too few clusters. In optimal
design literature,18,19 this is called the local optimality problem, since a design which is optimal for
some ICC value is not optimal for other values within the possible range [a,b] (called the parameter














2 6 10 14 18 22 26 30 34 38 42 46 50 n
Figure 1. Variance of the treatment effect estimator as a function of cluster size n (and implicitly also the number of
clusters K¼ B/(c + sn)), for several values of the ICC, assuming a sampling budget B¼ 100.000, sampling costs c¼ 2000
and s ¼ 100, and total outcome variance 2Y ¼ 100. Dotted lines indicate the LOD for each ICC value.
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(1) First, define the parameter and the design spaces. For example, the ICCmay be between a¼ 0.01
and b ¼ 0.10 (parameter space) based on previous studies, and the number of clusters K may be
between 4 and 80, and cluster size nmay be between 10 and 100 (design space), based on feasibility
constraints.
(2) For each ICC value in the parameter space, first compute the LOD with (5). Then, compute the
relative efficiency (RE) of each design in the design space compared with the LOD, by taking the
ratio of Equation (6) to (3).
(3) For each design in the design space, compute its minimum RE, that is, find its smallest RE value
within the parameter space. Then, select that design which maximizes the minimum RE, that is,
which has the highest minimum RE among all designs in the design space. This is the MMD and
its minimum RE is called the Maximin value (MMV).
These steps give the design which is most robust against misspecification of the ICC and thus most
cost-effective in the following sense: The inverse of theRE of a design versus the LOD gives the ratio of
the Var ̂1
 
’s under both designs for the same budget B, and thereby also the ratio of the budgets B
needed for the designs to have the same power and precision. Hence, a design with a minimum RE of
0.80 never needs more than 1/0.8¼ 1.25 times as much budget as the LOD, nomatter what the ICC is.
By maximizing the minimum RE, the MMD follows the optimal design as closely as possible over the
whole ICC range, and minimizes the worst-case budget increase relative to the optimal design.
Instead of using the RE, MMD can also use the efficiency as criterion. Maximizing not the
minimum RE, but the minimum efficiency itself, is equivalent to choosing the design which
minimizes the maximum Var ̂1
 
. This gives as solution the LOD for the maximum possible ICC
(which is b), since Var ̂1
 
is an increasing function of the ICC for any given design (n,K) (Equation
(3)). This design, denoted as LOD(b), is safe in considering the worst-case scenario of a high ICC.
However, it is highly dependent on the chosen ICC range and very inefficient if the ICC is close to its
lower boundary, which appears to occur quite frequently according to the ICC reviews.16,17
Moreover, the number of clusters increases with the ICC (Equation (5)) and so the LOD(b) may
not be feasible. In contrast, the MMD leads to a design that is optimal for some ICC value well within
the ICC range, while maximizing theRE for other ICC values, in particular for the ICC boundaries as
we will see. Also, the MMD requires fewer, though larger, clusters than the LOD(b). Both types of
MMD, based on the RE and based on efficiency, are found in the literature and will be compared in
this article. Two alternatives will also be compared with the MMDs: the LOD(a) design, which is the
LOD design for the smallest possible ICC, and the LOD(ab) design, which is the LOD design halfway
the ICC range, that is, at ICC ¼ (a+ b)/2. The LOD(a) minimizes the minimum Var ̂1
 
and is thus
an optimistic design. The LOD(ab) minimizes the expected Var ̂1
 
if the ICC is symmetrically
distributed over its range [a,b].
As the LOD(ab) already suggests, other solutions to the local optimality problem than Maximin
are possible. Using a Bayesian approach, one may maximize the expected instead of the minimum
efficiency, by integrating over a probability distribution for the ICC,36–39 thereby taking into account
that some ICC values within the range are more plausible than others. Or one can minimize the
expected instead of maximum Var ̂1
 
, giving the LOD(ab) in case of a symmetric ICC
distribution. These two Bayesian criteria will not, in general, give the same design, since efficiency
and Var ̂1
 
are non-linearly related. Also, the choice of the ICC probability distribution affects
the optimal design. Therefore, Bayesian design is beyond the present scope, apart from the special case
of the LOD(ab). So, let us look at the MMD based on relative efficiency (MMD) now, ignoring at
first any constraints on the design space apart from n, K> 0. Constraints are discussed at the end of
this section.
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Using Equations (3) and (6), we get the following expression for the relative efficiency of a given
design (n,K) compared with the LOD(), as a function of n and ICC:
RE n, ð Þ ¼
g ð Þ













as in (6), and K and B cancel out due to (4), making the RE a
function of cluster size n and ICC  only, given the costs c per cluster and s per person. The following
can now be shown (Appendix): If the parameter space for the ICC is the interval [a,b], where
0 a< b 1, then MMD, which maximizes the minimum of the RE in Equation (7), is
MMD : n ¼
b 1ð Þ g að Þ  a 1ð Þ g bð Þ
b g að Þ  a g bð Þ
, K ¼
B
c þ s n
ð8Þ
where g ð Þ is as defined in (6), and K follows from n in (8), using (4). By dividing g að Þ and g bð Þ by the
sampling cost per person s, it follows that the cluster size n of the MMD depends on the ICC
boundaries a and b and cost ratio c/s only. The costs c and s themselves and the budget B do not
affect the cluster size n, but the number of clusters K, of the MMD.
Further, the MMD attains its minimum RE or MMV at  ¼ a and at  ¼ b, the two minima
being equal for the MMD (Appendix), and this MMV is (Equation (7)):
MMV ¼
ng að Þ
naþ 1 að Þð Þ cþ snð Þ
, n ¼MMD ð9Þ
which just like the cluster size n for the MMD, depends on a and b and cost ratio c/s only, as can be
verified by dividing numerator and denominator of (9) by the cost per person s.
As a special case, if a ¼ 0 then g(a) ¼ s, and we obtain as MMD


















where the term ˇ(. . .) is the LOD(b) (Equation (5)). Hence, if a ¼ 0, then MMD has a cluster size n
equal to the cost ratio c/s plus twice the cluster size of the LOD (b) design.
Consequently, the MMD cluster size increases with the cost ratio, but decreases as the maximum
possible ICC value b increases, reaching a minimum of n ¼ c=s if b ¼ 1. In that case, half of the
budget is spent on clusters and half on persons (Equation (4)).
























which is decreasing both in b and in the cost ratio, reaching aminimumof 0.50 if b¼ 1. Of course, a¼ 0
gives an impossible optimal design by equation (5). However, Equations (10) and (11) give some
insight into the behaviour of MMD and MMV if a  0. Restricting the parameter space to an
interval [a,b] with 0< a< b< 1, gives a different MMD and a higher MMV. This is because the
minimum RE of any design is attained at either of the ICC boundaries (Appendix) and so the
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MMD LOD(a)LOD(b)
Figure 2. Plot of the relative efficiencies RE(n,a) and RE(n,b) of a design with cluster size n versus the locally optimal
designs LOD(a) and LOD(b), respectively, as a function of n, for a¼ 0.01 and b¼ 0.10 as lower and upper boundaries of
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(a)
(b)
Figure 3. Minimum relative efficiency (RE) in %, for the MMD and the LOD(b), LOD(a) and LOD(ab) design as a
function of the ICC upper boundary b, given a lower boundary a¼ 0.001 (panel a) or 0.01 (panel b), assuming the budget
and costs of Figure 1. The minimum RE of the LOD(b) and LOD(ab) is obtained at ICC value a, the minimum RE of the
LOD(a) at ICC value b, and the minimum RE of the MMD at both ICC values (Figure 2).
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MMD is the design (n,K), whichmaximizes theminimum ofRE (n,a) andRE(n,b), where bothREs are
obtained from (7). Figure 2 shows how this leads to the MMD, and technical details are given in
Appendix.
The results above assumed n, K> 0. In practice, there will be a lower bound larger than zero, and
an upper bound, on n and K. Given the costs and budget, bounds on n imply bounds on K and vice
versa. Hence, the derivation of the MMD can be repeated with a lower and upper bound for n,
ignoring K. It can be shown that this gives a slightly different MMD which approaches (8) as the
lower bound for nmoves to zero and the upper bound for n becomes large. Further, itsMMV is higher
than according to (9).
5 Performance of the designs in terms of relative efficiency and efficiency
MMDmaximizes the minimumRE and is thus robust against misspecification of the ICC if theMMV
is high enough. If a ¼ 0, it follows from (11) that the MMV decreases as b increases. With (9), it can
be shown that this also holds if a> 0. To give an impression, Figure 3 plots the MMV against b for
the cases a ¼ 0.001 and a ¼ 0.01, and with b up to 0.25. To compare, the minimum RE is also plotted
for the three locally optimal designs LOD(a), LOD(b) and LOD(ab), where ab refers to the midpoint
of the ICC range, that is, to (a + b)/2. Remember that, since Var ̂1
 
is an increasing function of
the ICC, the LOD(b) maximizes minimum efficiency instead of minimum RE, by minimizing the
maximum possible Var ̂1
 
. Similarly, LOD(a) minimizes the minimum possible Var ̂1
 
, and
LOD(ab) minimizes the expected Var ̂1
 
if the ICC is symmetrically distributed over [a,b].
Figure 3 shows that MMD clearly outperforms LODs, and more so as b increases. This is logical,
as the LOD(b) is very inefficient if   a and the LOD(a) is very inefficient if   b. For the same
reason, the LOD(ab) design performs better than both LOD(a) and LOD(b), although not as well as
theMMDwhich by definition gives the highest minimumRE. This minimumRE orMMVdepends on
the ICC range and cost ratio c/s. For example, in Figure 3 where c/s¼ 20, theMMV is 0.80 if a¼ 0.001
and b ¼ 0.10, but 0.96 if a ¼ 0.01 and b ¼ 0.05.
In terms of minimum efficiency (maximum variance) instead of minimum relative efficiency, things
are different since the LOD(b) has the highest minimum efficiency. For each design, Figure 4 plots the
relativeminimum efficiency, that is, the ratio of its minimum efficiency to theminimum efficiency of the
LOD(b). Now, LOD(b) outperforms the MMD, especially if a ¼ 0.001 and b is large. Figure 4 also
shows that the LOD(ab) design is almost as efficient as the LOD(b), and that the LOD(a) is very
inefficient. Note that the MMD and LOD(a) curves in Figure 4 are the same as in Figure 3, because
these twodesigns have theirminimumRE at the same ICC valuewhere their efficiency isminimum, that
is, at ICC ¼ b.
The efficiency criteria in Figures 3 and 4 can be combined by taking their average, which is an
example of a compound optimal design criterion.19 The performance of all designs by this criterion is
plotted in Figure 5, showing theMMD and LOD(ab) to perform equally well, and slightly better than
the LOD(b) and much better than the LOD(a). Finally, although all figures assumed a cost ratio c/s¼
20, similar plots and the same conclusions were obtained with other cost ratios, as will be seen in
Section 8.
6 Multicentre trials
Suppose that individual randomization is possible, but the study includes a large number of centres
(e.g. general practices) to recruit sufficient persons and test for treatment centre interaction.We then
have a multicentre trial, for which a simple model is
548 Statistical Methods in Medical Research 24(5)
Yij ¼ 0 þ 1Xij þ u0j þ u1jXij þ eij ð12Þ
where Yij is the outcome for person i in cluster (centre) j and Xij the treatment which is now coded
as+0.5 for treated and0.5 for control persons. The difference withmodel (1) for cluster randomized
trials is the additional random effect u1j with variance 
2
1 . This represents treatment  centre
interaction.
Assuming absence of covariance between u0j and u1j (i.e. 01 ¼ 0, implying homogeneity of
variance between treatment arms), and 50:50 allocation within each centre, the variance of ̂1






















1 , Equation (3) is obtained, from which the LOD and MMD for
cluster randomized trials were derived. Hence, Equations (5) and (8) for the LOD andMMDalso hold
for multicentre trials upon proper substitution. Using 0/1 coding for treatment in (3) gives
homogeneity of variance if 201 ¼ 
2
1 and a reparametrization of (13), but leads to the same
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Figure 4. Relative minimum efficiency (max Var ̂1
 
) in %, for the MMD and the LOD(b), LOD(a) and LOD(ab)
design as a function of the ICC upper boundary b, given a lower boundary a ¼ 0.001 or 0.01, assuming the budget and
costs of Figure 1. The minimum efficiency is obtained at ICC value b for all designs. Relative minimum efficiency is relative
to the LOD(b).
van Breukelen and Candel 549
7 Binary outcomes
Binary outcomes in a cluster randomized trial can be analysed by mixed logistic regression, among
others. The model of interest then is:
LN
P Yij ¼ 1
 
P Yij ¼ 0
 
 !
¼ 0 þ 1Xj þ u0j ð14Þ
where u0j is a random cluster effect with mean zero and variance 
2
0 . An expression for the variance of
















c 1 cð Þ
þ
1
t 1 tð Þ
 
ð15Þ
Here, 2 is the person-level variance on the log odds scale, similarly to  2e in the mixed linear model
(1), and c and t the probabilities P Yij ¼ 1
 












































Figure 5. Average of minimum relative efficiency and relative minimum efficiency in %, for the MMD and the LOD(b),
LOD(a) and LOD(ab) design as a function of the ICC upper boundary b, given a lower boundary a ¼ 0.001 or 0.01,
assuming the budget and costs of Figure 1.
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if u0j ¼ 0. This equation is based on first-order Marginal Quasi-Likelihood (MQL1) estimation,
which underestimates Var ̂1
 
. A fairly unbiased method is second-order Penalized Quasi-
Likelihood (PQL2), but no closed forms like Equation (15) can be derived for PQL2. However,
simulation studies show that multiplying Var ̂1
 
as computed with (15) with a factor 1.25 is a
safe correction for sample size planning8,26 when using PQL2.
What is important here is that (15) can be rewritten into (3) if we define 2 ¼ 2e . Since all equations
for the LOD and MMD were derived from (3), it follows that the results in this article also hold for
binary outcomes if we replace 2e with 
2 as defined in (15). Finally, the results can be extended to
multicentre trials with binary outcome by performing two substitutions in (3) simultaneously:
replacing  20 with 
2
1=4 and replacing 
2
e with 
2. In both cases, cluster randomized and multicentre
trial, Var ̂1
 
and by Equation (3) also the number of clusters K and budget B, must finally be
multiplied with the correction factor 1.25 for using PQL2 instead of MQL1.
8 Application and comparison with published trials
The theory of Sections 4 and 5 will now be applied to compute optimal and efficient designs for two
realistic ICC ranges, [0.001, 0.05] and [0.01, 0.10], and using as cost ratios c/s¼ 5, 20 and 50, based on a
reported cost ratio of c/s ¼ 26 in a cluster randomized smoking prevention study in primary
schools,1,41 as no information on sampling costs in other trials was found. For each combination
of ICC range and cost ratio, the cluster sizes of the MMD, LOD(a), LOD(b) and LOD(ab) were
computed as well as their minimum relative efficiency and relative minimum efficiency. The number of
clusters per design then follows from cluster size and budget (Equation (4)). Designs and efficiencies
are summarized in Table 2.
Table 2 shows several things. First, for every cost ratio and ICC range, the designs can be ordered as
LOD(a), MMD, LOD(ab), LOD(b) in terms of cluster size. Second, theMMD and LOD(ab) are both
Table 2. MMD and LOD at ICC values a, b and (a + b)/2 for cost ratios c/s ¼ 5, 20, 50 and ICC ranges [a,b] ¼ [0.001,
0.05] and [0.01, 0.10].
ICC range 0.001–0.05 ICC range 0.01–0.10
Cost ratio Design
Cluster









5 LOD(a) 70.7 0.45 0.45 22.3 0.72 0.72
MMD 19.7 0.90 0.90 11.4 0.93 0.93
LOD(ab) 13.8 0.83 0.97 9.3 0.89 0.97
LOD(b) 9.8 0.75 1.00 6.7 0.80 1.00
20 LOD(a) 141.4 0.43 0.43 44.5 0.72 0.72
MMD 43.5 0.86 0.86 24 0.92 0.92
LOD(ab) 27.7 0.74 0.97 18.5 0.85 0.98
LOD(b) 19.5 0.63 1.00 13.4 0.74 1.00
50 LOD(a) 223.5 0.44 0.44 70.4 0.75 0.75
MMD 74.8 0.83 0.83 39.5 0.92 0.92
LOD(ab) 43.7 0.67 0.97 29.3 0.83 0.98
LOD(b) 30.8 0.55 1.00 21.2 0.72 1.00
Notes: LOD(ab) is the LOD at the midpoint (a + b)/2 of the ICC range. Minimum relative efficiency (min RE) is attained at ¼ a or at ¼
b for every design. Relative minimum efficiency is the RE at  ¼ b with LOD(b) as a reference.
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quite efficient, with the MMD beating the LOD(ab) on minimum RE and the LOD(ab) beating the
MMD on relative minimum efficiency. The LOD(b) is of course even better on relative minimum
efficiency, but worse on minimumRE. The LOD(a) is worst on both criteria. Third, an increasing cost
ratio leads to larger clusters and an increasing ICC leads to smaller clusters, for all designs. Finally, the
optimal cluster size is between 10 and 50 for all cost ratios and ICC ranges considered, except one
MMD case and most LOD(a) cases.
What do these results imply for the actual study designs in Table 1? Cluster sizes much smaller than
10 andmuch larger than 50 do occur in various studies, but are far from optimal for the cost ratios and
ICC ranges in Table 2. Cluster sizes smaller than 10 are efficient only at cost ratios below 5 and/or ICC
ranges with an upper bound above 0.10. For instance, Equation (5) gives n ¼ 4 as the LOD(ab) at a
cost ratio c/s¼ 1 if the ICC range is [0.01, 0.10], or at c/s¼ 2 if the ICC range is [0.01, 0.20]. Likewise,
cluster sizes larger than 50 are efficient only at cost ratios above 50 and/or ICC ranges with b< 0.05 or
a ¼ 0. For example, n ¼ 100 is the LOD(ab) if the cost ratio is 100 and the ICC range is [0, 0.02].
This is not to say that the designs in Table 1 were ill-chosen, since a design choice also depends on
other considerations than costs, like feasibility. Sometimes, it is difficult to include more general
practices. A sample size of n> 50 per practice can then offer some compensation, although
Equation (3) shows that this compensation is ignorable if n is much larger than 1. Sometimes, it is
difficult to includemore patients per practice within the time frame of the study so that n< 10. This can
then be compensated by including more practices. However, the present results do indicate which
samples sizes are usually optimal or at least efficient. A researcher may first choose an optimal or
efficient design based on the present tables and equations. If that design is not feasible, one may then
choose the nearest (in terms of cluster size and number of clusters) design which is feasible.
9 Discussion
Starting from a simple model for the treatment effect on a quantitative outcome in a cluster
randomized trial, a practical expression was given for the optimal design (number of clusters,
number of persons per cluster) under budget and cost constraints. It was seen that the optimal
design depends not only on the sampling budget and costs, but also on the ICC which is rarely
known in study planning. This problem was handled using the Maximin procedure, leading to a
design which is robust against misspecification of the ICC in either of two senses: Having the
highest minimum relative efficiency (RE) compared with the optimal design (MMD), or having the
highest minimum efficiency (LOD(b)), where the minimum is taken over the ICC range. It was shown
that the MMD has a high minimum RE for realistic ICC ranges and cost ratios and can thus be
recommended for practical use in many cases. It was also shown that the LOD(ab), which is the LOD
at the midpoint of the ICC range, is a good alternative to the LOD(b) as it has almost the same
minimum efficiency and a higher minimumRE. ComparingMMDwith LOD(ab), the MMD is better
on minimum RE, the LOD(ab) is better on minimum efficiency, and they perform equally well on the
average of both criteria. Finally, the LOD(a) has a low minimum efficiency (high maximum Varð̂1Þ)
and a low minimum RE, so the LOD(a) is never to be recommended. It was also shown how the
theory applies to multicentre trials with treatment  centre interaction and to binary outcomes, and
the theory was illustrated with data from published cluster randomized trials.
There are several limitations and possible extensions to this study, which will now be touched upon.
First of all, we assumed equal cluster sizes, which are not very realistic. However, as discussed in
Section 1, current literature provides approximations for the relative efficiency of varying versus equal
cluster sizes based onCV of cluster sizes, which can be used to correct the total number of clustersK as
obtained with the equations in this article (for details, see Van Breukelen et al.14 and Candel and
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Van Breukelen26). As a second limitation, the mixed model of Equation (1) does not include any
covariates. Ignoring here possible treatment  covariate interaction, including a covariate has two
potential effects. On the one hand, it reduces unexplained outcome variance and thereby increases
power and precision of treatment effect estimation. This holds for standard clinical trials and also for
cluster randomized trials, as a cluster-level covariate reduces cluster-level variance  20 and a person-
level covariate reduces person-level variance  2e .
9 On the other hand, treatment–covariate correlation
increases Varð̂1Þ. However, cluster randomization ensures that treatment–covariate correlation goes
to zero for a cluster-level covariate as the number of clusters K increases, and that the correlation is
zero for a person-level covariate. Likewise, individual randomization as in multicentre trials ensures
that treatment–covariate correlation goes to zero for a person-level covariate as the total number of
persons nK increases and is zero for a cluster-level covariate.9 Ignoring covariates in sample size
planning is therefore a safe approach, while taking them into account may save money by reducing
outcome variance at each level of the design. A third limitation of the present work is that, compared
with Bayesian optimal design, MMD has the drawback of considering all ICC values in the assumed
range equally important, irrespective their prior probability. On the other hand, Maximin also has
several advantages over Bayesian design, notably ease of use and invariance of the design to
monotonic transformation of the optimality criterion. MMDs are easily computed with the
equations in this article and do not require the construction of a prior distribution for the ICC.
Further, using efficiency or variance as the design criterion gives the same MMD, but may give
different Bayesian designs since efficiency and variance are non-linearly related to each other. In
fact, Bayesian optimal design literature frequently uses as criterion the log efficiency,36,38 which
may give yet another Bayesian optimal design. A systematic comparison between Bayesian and
MMD under various priors and cost constraints is therefore desirable. A final limitation is that we
assumed homogeneity of variance and sampling costs between treatment arms, which may not always
be realistic.42 For the classical RCT without nesting, it has been shown43 that the optimal treatment-
to-control allocation ratio increases as the treatment-to-control variance ratio increases or as the
treatment-to-control cost ratio decreases. Ongoing work by the present authors gave a similar
result for the LOD of a cluster randomized trial with heterogeneous variances and costs. However,
as the two cluster-level variances and two person-level variances are unknown, MMD over a three-
dimensional space of variance ratios is needed, which is beyond the present scope.
To conclude, cost effectiveness, a widely accepted criterion for evaluating medical treatments and
public health programs, can also be used to evaluate clinical trials. Cost-effective design of cluster
randomized and multicentre trials increases the number of trials that can be run for the same budget.
However, this requires knowledge of the ICC range and of the cost ratio. It is therefore important that
publications of cluster randomized and multicentre trials provide information not only on ICCs,
but also on the costs per included cluster/centre and per person, to improve the design of future trials.
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1 APPENDIX
1.1 Derivation of the MMD and its minimum RE
The proof consists of the following steps: First, show that the relative efficiencyRE(n,) of design (n,K)
against LOD() is a single-peaked function of  with a maximum of 1 at the -value for which the
design (n,K) is itself optimal by Equation (5), and a minimum at either of the boundaries a and b for .
Second, show that RE(n,a) and RE(n,b) are single-peaked functions of cluster size n and that the
minimum RE is maximized by the design satisfying RE(n,a) ¼ RE(n,b). Third, find this design.
Step 1: Proof that the RE of design (n,K) is minimal at q ¼ a or at q ¼ b
From Equations (3) to (6), it follows that the RE of a design (n,K) versus the LOD() is:
RE n, ð Þ ¼
g ð Þ











1 ð Þ s
p 2
as in Equation (6), and K and B cancel out due to Equation
(4), making the RE a function of cluster size n and ICC  only, given the sampling costs c per cluster
and s per person upon which g ð Þ depends.















































which is the LOD of Equation (5). Denoting the  satisfying (A2) as 0 it can be verified that
@REðn,Þ
@  4 0 if a   5 0, and
@REðn, Þ
@  5 0 if 0 5   b, and so the RE attains its
maximum of 1 at 0, and its minimum either at  ¼ a or at  ¼ b, assuming 0 2 a, b½ . Designs
which are locally optimal for some 0  a have their maximumRE at  ¼ a and their minimumRE at
 ¼ b. Designs which are locally optimal for some 0  b have their maximum RE at  ¼ b and
their minimum RE at  ¼ a.
Step 2: Proof that min RE is maximized by the design satisfying RE(n,a)=RE(n,b)





n 1ð Þaþ 1½  cþ sn½ 
 2
 n 1ð Þaþ 1½  cþ sn½   na cþ snð Þ þ n ðn 1Þaþ 1ð Þs½ 
 
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, which is the LOD(a) as Equation (5) shows, giving RE(n,a) ¼ 1 if n ¼ na. It can be
verified that @REðn, aÞ@ n 4 0 if n 5 na and
@REðn, aÞ
@ n 5 0 if n4 na, and so RE(n,a) is a single-peaked






solution of @REðn, bÞ@ n ¼ 0, givingRE(n,b)¼ 1 as maximum at n ¼ nb. Further, since b> a, it follows that
nb 5 na. Hence, plotting both RE(n,a) and RE(n,b) as a function of cluster size n, we have that both
increase if n5 nb, that RE(n,b) already decreases whereas RE(n,a) still increases if nb 5 n5 na, and
that both decrease if n4 na. Since RE(n,b) and RE(n,a) both have a maximum value of 1, attained at
n ¼ nb and at n ¼ na, respectively, it follows that they intersect at some value n ¼ n0 which
satisfies nb 5 n0 5 na (Figure 2). Denote the common RE value at the intersection by RE0. Since
RE(n,a) is still increasing in n whereas RE(n,b) is already decreasing at n ¼ n0, it then follows that
REðn, aÞ5RE0 for all n 5 n0 and that REðn, bÞ 5 RE0 for all n 4 n0. In short,
min REðn, aÞ,REðn, bÞ
 
5RE0 for all n 6¼ n0, and so n ¼ n0 is the MMD and its minimum RE
value (MMV) is RE0.
Step 3: Derivation of the MMD
To find both the MMD n0 and its MMV RE0, observe that:
REðn, aÞ ¼ REðn, bÞ ) g að Þ n 1ð Þbþ 1½  ¼ gðbÞ n 1ð Þaþ 1½  ðA3Þ
which gives as the only possible solution:
n0 ¼
b 1ð Þ g að Þ  a 1ð Þ g bð Þ
bg að Þ  ag bð Þ
ðA4Þ
To show that n0 4 0, it is sufficient to show that denominator and numerator of (A4) are both positive
if b> a: Replacing, in the denominator of Equation (A4), g(a) and g(b) with their definition in
Equation (6) gives after some rewriting:












The part between the ½  sign can be verified to be positive for all b> a, and all other terms are likewise
positive. By similar rewriting the numerator of (A4) can be shown to be












The part between the ½  is again positive for all b> a, as are all other terms.
The MMV of the MMD is finally obtained by inserting (A4) into (7), giving Equation (9).
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